semaglutide 2024 Notable Articles of 2024: FLOW trial In patients with type 2 diabetes and chronic kidney disease, weekly significantly reduced risks of major kidney events, cardiovascular events, and death from any cause Senate launches investigation into high

Starting medication can bring hope, but also questions about what happens next and how to make results last

Kosowska A, Gallego-Colon E, Garczorz W, Klych-Ratuszny A, Aghdam MR, Woz Niak M, et al

The pharmacological properties of these medicines and their impact on glucose homeostasis inform UK blood service policies

Some research suggests they may be particularly helpful for women with other hormonal issues, including insulin resistance and polycystic ovarian syndrome (PCOS)

Semaglutide STRIDES on in #PAD in #T2D: The STRIDE Trial Peripheral artery disease (PAD) causes functional decline, pain, and disabilityand current medical treatments for walking impairment are outdated and underused

Lustig RH, Weiss R: Disorders of energy balance